Relative frequency of various forms of primary cutaneous lymphomas.

BACKGROUND Data on the relative frequency of the various forms of primary cutaneous lymphomas (PCLs) are largely limited to European institutions. OBJECTIVE Our purpose was to document the relative frequencies of various PCLs seen at 3 US institutions with active cutaneous lymphoma programs and to compare those with the European data. METHODS Included in this study are newly registered patients seen at MCP Hahnemann University, New York University, and the University of California, San Francisco from July 1, 1995 to June 30, 1998. RESULTS A total of 755 patients were seen. The frequency distribution of the major diagnostic groups was as follows: mycosis fungoides/Sézary syndrome, 82.3%; lymphomatoid papulosis, 12.6% (including patients with associated mycosis fungoides/Sézary syndrome); CD30(+) anaplastic large-cell lymphoma, 0.9%; peripheral T-cell lymphomas, 2.9%; B-cell lymphoma, 4.5%. CONCLUSION The most striking finding is the much lower relative frequency of primary cutaneous B-cell lymphomas at US institutions (4.5%) versus the approximately 20% reported by European groups. The reason for this difference requires further study.

[1]  Woodhead Gs,et al.  Primary cutaneous lymphomas other than mycosis fungoides. , 1999 .

[2]  M. Kashani-Sabet,et al.  Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. , 1999, Journal of the American Academy of Dermatology.

[3]  H. Vogt,et al.  Secondary lymph node involvement from primary cutaneous large B‐cell lymphoma of the leg , 1999, Cancer.

[4]  S. Whittaker,et al.  Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases , 1998, The British journal of dermatology.

[5]  H. Kerl,et al.  Infection by Borrelia burgdorferi and cutaneous B‐cell lymphoma , 1997, Journal of cutaneous pathology.

[6]  H. Kerl,et al.  EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. , 1997, Blood.

[7]  L. Cerroni,et al.  Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. , 1997, Journal of the American Academy of Dermatology.

[8]  M. Weinstock,et al.  Epidemiology and clinical manifestations of cutaneous T-cell lymphoma. , 1995, Hematology/oncology clinics of North America.

[9]  R. Dummer,et al.  Pathology of cutaneous T-cell lymphoma. , 1995, Hematology/oncology clinics of North America.

[10]  Slater Dn Review of investigative diagnostic techniques for cutaneous lymphoma. , 1994 .

[11]  P. Joly,et al.  Cutaneous lymphomas other than mycosis fungoides. , 1994, Seminars in dermatology.

[12]  C. Meijer,et al.  Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects. , 1992, The Journal of investigative dermatology.

[13]  H. Stein,et al.  Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. , 1991, Journal of the American Academy of Dermatology.

[14]  A. Hovmark,et al.  The spirochetal etiology of lymphadenosis benigna cutis solitaria. , 1986, Acta dermato-venereologica.

[15]  H. Kerl,et al.  Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas. , 1984, The Journal of Dermatologic Surgery and Oncology.

[16]  Professor Dr. Günter Burg,et al.  Cutaneous Lymphomas, Pseudolymphomas, and Related Disorders , 1982, Springer Berlin Heidelberg.